PRIORITY-CONNECT 2 Trial

Recruiting · NCT06976710 · Interventional (participants receive a specific treatment) · Lead sponsor: Surgical Outcomes Research Centre (SOuRCe)

Interventions studied

What this trial is about

Objectives: The primary aim of this project is to establish the effectiveness of an individualised stepped, multidisciplinary intervention, including education and peer support group, delivered via a virtual multimodal (p)rehabilitation hub, in reducing postoperative complications within 30-days following colorectal cancer surgery, compared to usual care alone. The secondary aims will be to obtain data on the likely difference in key outcomes including: (i) Quality of life (EORTC QLQ-C30 and QLQ-CR29) (ii) Number of days at home within 30, 90 and 365 days after surgery (DAH-30, 90, 365) (iii) Quality of recovery (QoR-15) (iv) Cost-effectiveness (v) Implementation metrics (RE-AIM) Our hypothesis is that the PRIORITY-CONNECT 2 intervention will be more effective in reducing postoperative complications and more cost-effective than usual care. Study design: Pragmatic Randomised Type I Hybrid Effectiveness-Implementation Trial. Planned sample size: To achieve the primary aim, 564 participants will provide 90% power to detect a 15% difference in 30-day postoperative complication rates between the intervention and control groups. The sample size calculation accounts for up to 10% loss to follow-up, 5% non-compliance and a two-side alpha of 0.05. Selection criteria: A sample of 564 participants undergoing colorectal cancer surgery including open, laparoscopic or robotic-assisted surgery (mostly, anterior resection, sigmoid colectomy, hemicolectomy, total proctocolectomy, subtotal colectomy, total colectomy) at sites throughout Australia will be included. These are common colorectal cancer surgeries performed at the participating centres. All the surgeons involved in this study have clinical appointments in their respective hospitals. Inclusion: Adults aged ≥18 years undergoing elective major surgery for colon or rectal cancer with curative intent; and consulting a colorectal surgeon at least 1 week prior to scheduled surgery. Exclusion: Patients undergoing Pelvic Exenteration (PE), Cytoreductive Surgery (CRS) with or without HIPEC, or concurrent surgery for metastatic disease; or cognitive impairment such that they are unable to provide informed consent. Study Procedure: Participant's treating team will screen and provide an information sheet about the trial to consecutive patients. Interested patients will be contacted by a study researcher to discuss the trial further, answer any questions, confirm eligibility against the inclusion and exclusion criteria, and consent patients. Consenting patients will undergo baseline assessment and be randomised to a virtual multimodal hub (Intervention group) or usual care alone (Control group). The intervention will include the delivery of usual care and evidence-based exercise, nutritional, psychological and nursing interventions, and / or group-delivered peer support. All interventions will be conducted before and after surgery. Duration of the Study: Approximately 60 months. Funding: Medical Research Future Fund (MRFF) 2023 Early and Mid-Career Researchers (Application ID: 2031563). Sponsor: The University of Sydney.

Who can take part

Where it is running

31 locations listed.

• Coffs Harbour Health Campus - Coffs Harbour, New South Wales, Australia
• Calvary Mater Hospital - Newcastle, New South Wales, Australia
• John Hunter Hospital - Newcastle, New South Wales, Australia
• Chris O'Brien Lifehouse - Sydney, New South Wales, Australia
• Royal Prince Alfred Hospital - Sydney, New South Wales, Australia
• Concord Repatriation General Hospital - Sydney, New South Wales, Australia
• Westmead Hospital - Sydney, New South Wales, Australia
• Blacktown Hospital - Sydney, New South Wales, Australia
• Wagga Wagga Base Hospital - Wagga Wagga, New South Wales, Australia
• Wollongong Hospital - Wollongong, New South Wales, Australia
• Royal Brisbane & Women's Hospital - Brisbane, Queensland, Australia
• Princess Alexandra Hospital - Brisbane, Queensland, Australia
• The Queen Elizabeth II Jubilee Hospital - Brisbane, Queensland, Australia
• Royal Adelaide Hospital - Adelaide, South Australia, Australia
• Flinders Medical Centre - Adelaide, South Australia, Australia
• Modbury Hospital - Adelaide, South Australia, Australia
• Lyell McEwin Hospital - Adelaide, South Australia, Australia
• Grampians Health Ballarat Hospital - Ballarat, Victoria, Australia
• Bendigo Health - Bendigo, Victoria, Australia
• University Hospital Geelong (Barwon Health) - Geelong, Victoria, Australia
• Peter MacCallum Cancer Centre - Melbourne, Victoria, Australia
• Alfred Hospital - Melbourne, Victoria, Australia
• Footscray Hospital - Melbourne, Victoria, Australia
• Werribee Mercy Hospital - Melbourne, Victoria, Australia
• Royal Melbourne Hospital - Melbourne, Victoria, Australia
• St Vincent's Melbourne Hospital - Melbourne, Victoria, Australia
• Northern Hospital Epping - Melbourne, Victoria, Australia
• Austin Hospital - Melbourne, Victoria, Australia
• Eastern (Box Hill) Hospital - Melbourne, Victoria, Australia
• Cabrini Hospital - Melbourne, Victoria, Australia
• Royal Perth Hospital - Perth, Western Australia, Australia